Recent advances in paclitaxel biosynthesis and regulation
2024

Advances in Paclitaxel Production and Regulation

publication Evidence: moderate

Author Information

Author(s): Toby Coombe-Tennant, Xiaoping Zhu, Shihua Wu, Gary J. Loake, Rainer Melzer

Primary Institution: University of Edinburgh

Hypothesis

How can we improve the biosynthesis and regulation of paclitaxel in plant cell cultures?

Conclusion

Recent research has identified key genes and regulatory mechanisms that could enhance paclitaxel production in plant cell cultures.

Supporting Evidence

  • Paclitaxel is crucial for treating various cancers and its demand is increasing.
  • Recent genome sequencing of Taxus species has revealed important genes for paclitaxel biosynthesis.
  • Plant cell cultures can be optimized to produce paclitaxel sustainably.

Takeaway

Scientists are figuring out how to make more of a medicine called paclitaxel from plants by understanding how it grows and how to help it grow better.

Methodology

The study reviews recent advances in understanding paclitaxel biosynthesis and its regulation through transcriptomic approaches and genome sequencing.

Limitations

The production of paclitaxel in heterologous hosts remains low and requires further optimization.

Digital Object Identifier (DOI)

10.1093/jxb/erae240

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication